• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

(R)-3-Aminopentanoic Acid: A Key Compound in Biochemical Research and Pharmacological Applications

(R)-3-Aminopentanoic acid, also known by its CAS No. 131347-76-7, is a chiral amino acid that has garnered significant attention in both academic and industrial research due to its unique structural properties and potential therapeutic applications. This compound belongs to the family of α-amino acids, which are fundamental building blocks of proteins and play critical roles in cellular signaling, metabolic pathways, and drug development. The stereochemistry of (R)-3-Aminopentanoic acid is particularly intriguing, as the spatial arrangement of its functional groups can influence its biological activity, pharmacokinetics, and interactions with target proteins. Recent studies have highlighted its potential in modulating neurodegenerative processes, inflammatory responses, and metabolic disorders, making it a focal point in modern biomedical research.

The molecular structure of (R)-3-Aminopentanoic acid consists of a five-carbon backbone with an amino group at the third carbon position and a carboxylic acid group at the terminal end. This configuration distinguishes it from other amino acids like glycine or alanine, which have shorter chains. The stereochemical configuration of the molecule, specifically the (R) configuration, is crucial for its biological function. Unlike its (S) enantiomer, which may exhibit different pharmacological profiles, the (R) form has been shown to possess unique properties that make it a valuable tool in drug discovery and biochemical assays. Researchers are increasingly focusing on understanding how the stereochemistry of this compound affects its interactions with biological targets, such as ion channels, receptors, and enzymes.

Recent advances in synthetic biology and chemical synthesis have enabled the efficient production of (R)-3-Aminopentanoic acid, which has opened new avenues for its application in pharmaceutical development. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that (R)-3-Aminopentanoic acid could act as a precursor for designing novel drugs targeting neurodegenerative diseases. The study highlighted its ability to inhibit the aggregation of amyloid-beta proteins, a key factor in Alzheimer’s disease pathology. This finding underscores the compound’s potential as a therapeutic candidate for age-related neurological disorders. Additionally, its role in modulating the activity of metalloproteases, which are implicated in tumor progression, has been explored in recent preclinical trials.

From a metabolic perspective, (R)-3-Aminopentanoic acid is involved in several biochemical pathways, including the urea cycle and the synthesis of polyamines, which are essential for cell proliferation and differentiation. Researchers have also investigated its role in the regulation of glutamate metabolism, a critical process in synaptic transmission and neuronal function. A 2022 study in Nature Communications revealed that (R)-3-Aminopentano,ic acid could modulate the activity of glutamate transporters, thereby influencing neurotransmitter homeostasis. This discovery has significant implications for the treatment of neurological conditions such as epilepsy and stroke, where glutamate imbalance plays a central role.

Pharmacologically, (R)-3-Aminopentanoic acid has demonstrated promising therapeutic potential in various disease models. For instance, its ability to reduce oxidative stress and inflammation has been explored in the context of autoimmune diseases and chronic inflammatory conditions. A 2021 study in Cell Reports showed that (R)-3-Aminopentanoic acid could suppress the activation of NLRP3 inflammasomes, which are key players in the innate immune response. This property makes it a potential candidate for the development of anti-inflammatory drugs. Moreover, its role in enhancing the efficacy of chemotherapeutic agents by modulating drug resistance pathways has been the subject of ongoing research.

The synthesis of (R)-3-Aminopentanoic acid has been optimized using asymmetric catalytic methods, which allow for the selective production of the (R) enantiomer with high purity. These synthetic strategies are critical for ensuring the compound’s suitability in pharmaceutical applications, where enantiomeric purity is essential for minimizing side effects and maximizing therapeutic efficacy. Additionally, the development of scalable and cost-effective synthesis routes has facilitated its use in both academic research and industrial settings. This progress has enabled researchers to conduct large-scale studies on its biological effects, further advancing our understanding of its potential therapeutic applications.

Despite its promising properties, the exact mechanisms by which (R)-3-Aminopentanoic acid exerts its biological effects remain under investigation. Ongoing studies are focused on elucidating its interactions with specific receptors, enzymes, and signaling pathways. For example, recent work has explored its potential as a modulator of the Wnt/β-catenin signaling pathway, which is implicated in cancer development and tissue regeneration. These findings suggest that (R)-3-Aminopentanoic acid could have broader applications beyond its current therapeutic scope, including regenerative medicine and anti-cancer therapies.

In summary, (R)-3-Aminopentanoic acid represents a versatile compound with significant potential in biomedical research. Its unique stereochemistry, involvement in key metabolic pathways, and demonstrated therapeutic effects make it a valuable target for drug development. As research continues to uncover its mechanisms of action and expand its applications, (R)-3-Aminopentanoic acid is poised to play a pivotal role in addressing complex diseases and advancing the field of pharmacology.

• 58521-63-4(3-Amino-hexanoic Acid)
• 89687-33-2(Heptanoic acid,3,7-diamino-)
• 71288-40-9(Heptanedioic acid, 3-amino-)
• 18664-78-3(3-Amino-pentanoic Acid)
• 14389-77-6((S)-3-Aminopentanoic acid)
• 5427-96-3(3-Aminoadipic acid)
• 336182-10-6(H-beta-HoAsp?HCl)
• 1948-48-7(β-Glutamic Acid)
• 104883-49-0(3-Aminooctanoic acid)
• 104883-48-9(3-Aminoheptanoic acid)